http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#head http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#assertion http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#provenance http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#assertion http://rdf.disgenet.org/resource/gda/DGN47f0c26e2d821e9bb2d5172965b7bfc0 http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/5609 http://rdf.disgenet.org/resource/gda/DGN47f0c26e2d821e9bb2d5172965b7bfc0 http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C1140680 http://rdf.disgenet.org/resource/gda/DGN47f0c26e2d821e9bb2d5172965b7bfc0 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001123 http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#provenance http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#assertion http://purl.org/dc/terms/description [We assess key issues in anti-angiogenic treatment including potential ways for addressing resistance; we review the current studies of PARP inhibitor treatment, which shows most promise in patients with germline BRCA mutations; we describe the potential for folate-receptor-directed therapy, given the high level of FR expression in ovarian cancer and we highlight the potential for molecular targeted therapy, focusing on specific subgroups of the disease with targets such as the PI3 K/AKT and RAS/RAF/MEK pathways and the ErbB family of oncogenes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/24265409 http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://purl.org/dc/terms/created 2017-10-17T13:15:39+02:00 http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP858951.RAfllzUYssCdhqDXMIP5riusojrMCi1_VP0DOP6IHLHC4 http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0